Survey of HAART/ART in HIV/AIDS Patient
viral load and restoring the immune system. Once patients start Highly Active Antiretroviral Therapy (HAART), it is to be continued lifelong in spite of its many adverse side effects. Zidovudine
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
viral load and restoring the immune system. Once patients start Highly Active Antiretroviral Therapy (HAART), it is to be continued lifelong in spite of its many adverse side effects. Zidovudine
viral load and restoring the immune system. Once patients start highly active antiretroviral therapy (HAART), it must be continued throughout life despite its many unwanted side effects. Zidovudine
process. Method: This was a cross-sectional case-control study. One hundred newly diagnosed HAART naïve HIV/ AIDS individuals seen in the retroviral clinic were evaluated clinically. One hundred
bilirubin due to use of atazanavir. PatientâÂ?Â?s Highly Active Anti-Retroviral Therapy (HAART) regimen was therefore changed, leading to a slow improvement in bilirubin levels. Conclusion: Hyperbilirubinemia
indirect bilirubin due to use of atazanavir. Patient’s Highly Active Anti-Retroviral Therapy (HAART) regimen was therefore changed, leading to a slow improvement in bilirubin levels. Conclusion: Hyperbilirubinemia
with a decreasing incidence, probably related to the widespread utilization increased of HAART. Our results may serve as a benchmark reference to other Spanish centers
Background: Highly active antiretroviral therapy (HAART) offered HIV-positive individuals tremendous lifesustaining benefits. The benefits are sustainable only through optimal adherence. This systematic review was…
metabolism, particularly, if considered that lipodystrophy is one of the main collateral effects of HAART in humans. Indeed, lipid alterations are detected in HIV PIs-treated Leishmania cells
have been identified to have a virus with a high level resistance to HAART drugs, in 38 (64.4%) patients mutation M184V/I was identified. In 27 (45.8%) patients (13 female
therapy, major complications and metabolic abnormalities that occur as a consequence of HAART. The effect of antiretroviral (ARV) therapies on the incidence of serious non-AIDS events (SNAEs) has also
Background: The rate of prevalence of HIV among adults has been increasing
According to World Health Organization (WHO), Dolutegravir-based regimen is considered as
Aim:However, advances in Human Immunodeficiency Virus (HIV) biology, pharmacology and clinical
The study is aimed at identifying clinical, demographic and behavioral factors, including
vaginitis among HIV seropositive women before and after initiation of highly active antiretroviral therapy (HAART). Materials and Methods: A cross-sectional and prospective study was carried out between July ... Vaginal…
Methicillin-resistant Staphylococcus aureus (MRSA) is said to be any strain of
Background: Zidovudine is one of a nucleoside reverse transcriptase inhibitor in the
Efavirenz has been a mainstay of HAART since its introduction in 1998. Though recently downgraded by DHHS from a first-line to an alternative treatment due to risk of neuropsychiatric ... South African guidelines…
Background: Highly active anti-retroviral therapy (HAART) has brought significant change in reducing morbidity and mortality among children living with HIV/AIDS. However, proper monitoring of HAART response is found…
For authors and organisers
Find the right journal for your paper and submit your manuscript.